Pediatric Brain Tumors

Advances in Pediatrics

Volumn 56, Issue 1, 2009, Pages 249-269

  Grondin, Ronald T ^a   Scott, R Michael ^b   Smith, Edward R ^b  

^a OHIO STATE UNIVERSITY   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR MARKER;

BRAIN; BRAIN TUMOR; CHILD; DIAGNOSTIC IMAGING; HUMAN; NEOPLASM; NEUROLOGIC EXAMINATION; PATHOLOGY; REVIEW;

BRAIN; BRAIN NEOPLASMS; CHILD; DIAGNOSTIC IMAGING; HUMANS; NEOPLASMS, GERM CELL AND EMBRYONAL; NEUROLOGIC EXAMINATION; TUMOR MARKERS, BIOLOGICAL;

EID: 72049097392     PISSN: 00653101     EISSN: None     Source Type: Book Series    
DOI: 10.1016/j.yapd.2009.08.006     Document Type: Review

References (68)

1. Smith E.R., Butler W.E., and Barker II F.G. Craniotomy for resection of pediatric brain tumors in the United States, 1988-2000: effects of provider caseloads and progressive centralization and specialization of care. Neurosurgery 54 (2004) 553-563 [discussion: 563-65]
2. Surawicz T.S., Davis F., Freels S., et al. Brain tumor survival: results from the National Cancer Data Base. J Neurooncol 40 (1998) 151-160
3. Surawicz T.S., McCarthy B.J., Kupelian V., et al. Descriptive epidemiology of primary brain and CNS tumors: results from the Central Brain Tumor Registry of the United States, 1990-1994. Neuro Oncol 1 (1999) 14-25
4. Barker II F.G., Curry Jr. W.T., and Carter B.S. Surgery for primary supratentorial brain tumors in the United States, 1988 to 2000: the effect of provider caseload and centralization of care. Neuro Oncol 7 (2005) 49-63
5. Farwell J.R., Dohrmann G.J., and Flannery J.T. Intracranial neoplasms in infants. Arch Neurol 35 (1978) 533-537
6. Fernandez C.A., Yan L., Louis G., et al. The matrix metalloproteinase-9/neutrophil gelatinase-associated lipocalin complex plays a role in breast tumor growth and is present in the urine of breast cancer patients. Clin Cancer Res 11 (2005) 5390-5395
7. Medina L.S., Pinter J.D., Zurakowski D., et al. Children with headache: clinical predictors of surgical space-occupying lesions and the role of neuroimaging. Radiology 202 (1997) 819-824
8. Keles G.E., Banerjee A., Puri D., et al. Supratentorial gliomas. In: Gupta N., Banerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin
9. Kim I.Y., Niranjan A., Kondziolka D., et al. Gamma knife radiosurgery for treatment resistant choroid plexus papillomas. J Neurooncol 90 (2008) 105-110
10. In: Ries L.A.G., Eisner E.P., Kosary C.L., et al. (Eds). SEER Cancer Statistics Review, 1975-2000 (2003), National Cancer Institutue, Bethesda (MD)
11. Dohrmann G.J., Farwell J.R., and Flannery J.T. Astrocytomas in childhood: a population-based study. Surg Neurol 23 (1985) 64-68
12. Taylor T., Jaspan T., Milano G., et al., PLAN Study group. Radiological classification of optic pathway gliomas: experience of a modified functional classification system. Br J Radiol 81 (2008) 761-766
13. Binning M.J., Liu J.K., Kestle J.R., et al. Optic pathway gliomas: a review. Neurosurg Focus 23 (2007) E2
14. Mehta V., Chapman A., McNeely P.D., et al. Latency between symptom onset and diagnosis of pediatric brain tumors: an Eastern Canadian geographic study. Neurosurgery 51 (2002) 365-372
15. Pollack I.F., Gerszten P.C., Martinez A.J., et al. Intracranial ependymomas of childhood: long-term outcome and prognostic factors. Neurosurgery 37 (1995) 655-666 [discussion: 666-67]
16. Packer R.J., Sutton L.N., Bilaniuk L.T., et al. Treatment of chiasmatic/hypothalamic gliomas of childhood with chemotherapy: an update. Ann Neurol 23 (1988) 79-85
17. Bloom H.J., Glees J., Bell J., et al. The treatment and long-term prognosis of children with intracranial tumors: a study of 610 cases, 1950-1981. Int J Radiat Oncol Biol Phys 18 (1990) 723-745
18. Packer R.J., Ater J., Allen J., et al. Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas. J Neurosurg 86 (1997) 747-754
19. Gururangan S., Cavazos C.M., Ashley D., et al. Phase II study of carboplatin in children with progressive low-grade gliomas. J Clin Oncol 20 (2002) 2951-2958
20. Sposto R., Ertel I.J., Jenkin R.D., et al. The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group. J Neurooncol 7 (1989) 165-177
21. Finlay J.L., Boyett J.M., Yates A.J., et al. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group. J Clin Oncol 13 (1995) 112-123
22. von Koch C.S., Schmidt M.H., and Perry V. Neuronal tumors. In: Gupta N., Barnerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 143-55
23. Johannssen J.H., Rekate H.L., and Roessmann U. Gangliogliomas: pathological and clinical correlation. J Neurosurg 54 (1981) 58-63
24. Johnson Jr. J.H., Hariharan S., Berman J., et al. Clinical outcome of pediatric gangliogliomas: ninety-nine cases over 20 years. Pediatr Neurosurg (1997) 203-207
25. Morris H.H., Estes M.L., Gilmore R., et al. Chronic intractable epilepsy as the only symptom of primary brain tumor. Epilepsia 34 (1993) 1038-1043
26. Wolf H.K., and Weister O.D. Surgical pathology of chronic epileptic seizure disorder. Brain Pathol 3 (1993) 371-380
27. Hassoun J., Soylemezoglu F., Gambarelli D., et al. Central neurocytoma: a synopsis of clinical and histological features. Brain Pathol 3 (1993) 297-306
28. Osborn A.G., Blazer S., and Saltzman K. Diagnostic imaging: brain (2004), AMIRSYS, Salt Lake City (UT)
29. Benifla M., Otsubo H., Ochi A., et al. Temporal lobe surgery for intractable epilepsy in children: an analysis of outcomes in 126 children. Neurosurgery 59 (2006) 1203-1213 [discussion: 1213-14]
30. Lieuw K.H., Haas-Kogan D., and Ablin A. Intracranial germ cell tumors. In: Gupta N., Banerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 107-21
31. Wisoff J.H., and Donahue B.R. Craniopharyngiomas. In: Albright A.L., Pollack I., and Adelson P.D. (Eds). Principles and practice of pediatric neurosurgery (2008), Thieme, New York
32. Du R., Lustig R.H., Fisch B., et al. Craniopharyngioma. In: Gupta N., Barnerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 132-42
33. Ellenbogen R.G., Winston K.R., and Kupsky W.J. Tumors of the choroid plexus in children. Neurosurgery 25 (1989) 327-335
34. Moore K., and Couldwell W.T. Craniopharyngioma. In: Bernstein M., and Berger M.S. (Eds). Neuro-oncology: the essentials (2000), Thieme, New York p. 409-18
35. Taylor M.D., Sanford R.A., and Boop F.A. Cerebellar pilocytic astrocytomas. In: Albright A.L., Pollack I., and Adelson P.D. (Eds). Principles and practice of pediatric neurosurgery. 2nd edition (2008), Thieme, New York p. 655-67
36. Burkhard C., Di Patre P.L., Schüler D., et al. A population-based study of the incidence and survival rates in patients with pilocytic astrocytoma. J Neurosurg 98 (2003) 1170-1174
37. Chi J.H., and Gupta N. Cerebellar astrocytomas. In: Gupta N., Banerjee A., and Haas-Koogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 27-47
38. Fisher P.G., Tihan T., Goldthwaite P.T., et al. Outcome analysis of childhood low-grade astrocytomas. Pediatr Blood Cancer 51 (2008) 245-250
39. Pan E., and Prados M. Brainstem gliomas. In: Gupta N., Barnerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 29-43
40. Jallo G.I., Biser-Rohrbaugh A., and Freed D. Brainstem gliomas. Childs Nerv Syst 20 (2004) 143-153
41. Farmer J.P., Montes J.L., Freeman C.R., et al. Brainstem gliomas. A 10-year institutional review. Pediatr Neurosurg 34 (2001) 206-214
42. Farmer J.P., McNeely P.D., and Freeman C.R. Brainstem Gliomas. In: Albright A.L., Pollack I., and Adelson P.D. (Eds). Principles and practice of pediatric neurosurgery. 2nd edition (2008), Thieme, New York p. 640-54
43. Horn B.N., and Smyth M. Ependymoma. In: Gupta N., Barnerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 65-81
44. Grill J., Renaux V.K., Bulteau C., et al. Long-term intellectual outcome in children with posterior fossa tumors according to radiation doses and volumes. Int J Radiat Oncol Biol Phys 45 (1999) 137-145
45. Fisher P.G. Embryonal tumors. In: Gupta N., Banerjee A., and Haas-Kogan D. (Eds). Pediatric CNS tumors (2004), Springer, Berlin p. 83-105
46. Packer R.J., Rood B.R., and MacDonald T.J. Medulloblastoma: present concepts of stratification into risk groups. Pediatr Neurosurg 39 (2003) 60-67
47. Horska A., Ulug A.M., Melhem E.R., et al. Proton magnetic resonance spectroscopy of choroid plexus tumors in children. J Magn Reson Imaging 14 (2001) 78-82
48. Humphreys R.P., Nemoto S., Hendrick E.B., et al. Childhood choroid plexus tumors. Concepts Pediatr Neurosurg 7 (1987) 1-18
49. Davies N.P., Wilson M., Harris L.M., et al. Identification and characterisation of childhood cerebellar tumours by in vivo proton MRS. NMR Biomed 21 (2008) 908-918
50. Sutherland G.R., Latour I., Greer A.D., et al. An image-guided magnetic resonance-compatible surgical robot. Neurosurgery 62 (2008) 286-292 [discussion: 292-93]
51. Bergers G., Brekken R., McMahon G., et al. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2 (2000) 737-744
52. Fang J., Shing Y., Wiederschain D., et al. Matrix metalloproteinase-2 is required for the switch to the angiogenic phenotype in a tumor model. Proc Natl Acad Sci U S A 97 (2000) 3884-3889
53. Moses M.A., Sudhalter J., and Langer R. Identification of an inhibitor of neovascularization from cartilage. Science 248 (1990) 1408-1410
54. Beliveau R., Delbecchi L., Beaulieu E., et al. Expression of matrix metalloproteinases and their inhibitors in human brain tumors. Ann NY Acad Sci (1999) 236-239
55. Kunishio K., Okada M., Matsumoto Y., et al. Matrix metalloproteinase-2 and -9 expression in astrocytic tumors. Brain Tumor Pathol 20 (2003) 39-45
56. Lampert K., Machein U., Machein M.R., et al. Expression of matrix metalloproteinases and their tissue inhibitors in human brain tumors. Am J Pathol 153 (1998) 429-437
57. Laurence K.M. The biology of choroid plexus papilloma in infancy and childhood. Acta Neurochir (Wien) 50 (1979) 79-90
58. Lena G., Genitori L., Molina J., et al. Choroid plexus tumours in children. Review of 24 cases. Acta Neurochir (Wien) 106 (1990) 68-72
59. Noha M., Yoshida D., Watanabe K., et al. Suppression of cell invasion on human malignant glioma cell lines by a novel matrix-metalloproteinase inhibitor SI-27: in vitro study. J Neurooncol 48 (2000) 217-223
60. Paek S.H., Kim D.G., Park C.K., et al. The role of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinase in microcystic meningiomas. Oncol Rep 16 (2006) 49-56
61. Park C.M., Park M.J., Kwak H.J., et al. Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-Kinase/Akt signaling pathways. Cancer Res 66 (2006) 8511-8519
62. Pollack I. Supratentorial hemispheric gliomas. In: Albright A.L., Pollack I., and Adelson P.D. (Eds). Principles and practice of pediatric neurosurgery. 2nd edition (2008), Thieme, New York p. 511-30
63. Thier M., Roeb E., Breuer B., et al. Expression of matrix metalloproteinase-2 in glial and neuronal tumor cell lines: inverse correlation with proliferation rate. Cancer Lett 149 (2000) 163-170
64. Zhao J.X., Yang L.P., Wang Y.F., et al. Gelatinolytic activity of matrix metalloproteinase-2 and matrix metalloproteinase-9 in rat brain after implantation of 9L rat glioma cells. Eur J Neurol 14 (2007) 510-516
65. Chan L.W., Moses M.A., Goley E., et al. Urinary VEGF and MMP levels as predictive markers of 1-year progression-free survival in cancer patients treated with radiation therapy: a longitudinal study of protein kinetics throughout tumor progression and therapy. J Clin Oncol 22 (2004) 499-506
66. Moses M.A., Wiederschain D., Loughlin K.R., et al. Increased incidence of matrix metalloproteinases in urine of cancer patients. Cancer Res 58 (1998) 1395-1399
67. Roy R., Wewer U.M., Zurakowski D., et al. ADAM 12 cleaves extracellular matrix proteins and correlates with cancer status and stage. J Biol Chem 279 (2004) 51323-51330
68. Yan L., Borregaard N., Kjeldsen L., et al. The high molecular weight urinary matrix metalloproteinase (MMP) activity is a complex of gelatinase B/MMP-9 and neutrophil gelatinase-associated lipocalin (NGAL). Modulation of MMP-9 activity by NGAL. J Biol Chem 276 (2001) 37258-37265